Drug class in one race
Folate receptor alpha (FRα) drugs for Non-Small Cell Lung Cancer
2 tracked Folate receptor alpha (FRα) drugs in the Non-Small Cell Lung Cancer race. The class explanation lives on the Folate receptor alpha (FRα) page; the full indication pipeline across every mechanism is on the Non-Small Cell Lung Cancer page.
1 Phase 21 Phase 1